Wei Ding
About Wei Ding
Wei Ding is the Associate Scientific Director at Bristol-Myers Squibb in New Brunswick, NJ, with extensive expertise in HRAM LC-MS/MS and a Ph.D. in Chemistry from the University of Georgia.
Title and Current Roles
Wei Ding currently holds the position of Associate Scientific Director at Bristol-Myers Squibb (BMS) in New Brunswick, NJ, USA. In addition to this role, he serves as a Sr. Research Investigator II at the same location. His responsibilities in these roles encompass a range of scientific and research activities aimed at advancing pharmaceutical development and production.
Educational Background
Wei Ding pursued his higher education at the University of Georgia, Athens, GA, USA, where he studied Chemistry. He earned a Doctor of Philosophy (Ph.D.) degree between 1998 and 2002. During his Ph.D. studies, Ding developed a strong foundation in chemical research, which he has since leveraged in his professional career.
Research and Methodology Development
Wei Ding has developed a novel high-resolution accurate mass (HRAM) LC-MS and LC-MS/MS based characterization methodology for polyethylene glycols (PEGs) up to 20 kDa. This includes the characterization of branched PEG architectures and PEGs with various end-groups. This methodology showcases his ability to innovate and contribute significantly to the field of mass spectrometry and analytical chemistry.
Awards and Recognitions
Wei Ding has received multiple awards in recognition of his contributions to the field of chemistry and pharmaceutical development. These include the 2013 Chemistry Leadership Award at BMS for his critical contributions through innovative methods for determining genotoxic impurities, the BMS Encore Recognition for his outstanding work on the HCV NS3 GTI issue in March 2016, and the BMS R&D Star Award for his analytical efforts related to trace levels of slip agents in February 2014.
Expertise and Technical Skills
Wei Ding possesses extensive experience in the identification and structural elucidation of process impurities and degradants in drug substances and products using HRAM LC-MS/MS. He is skilled in the operation and troubleshooting of mass spectrometers and LC-MS systems from multiple platforms, including Thermo, Waters, and Sciex. Ding's expertise also includes LC-MS/MS for genotoxic impurity (GTI) quantification, trace analysis, and bioanalysis, as well as NMR analysis and spectra interpretation for MS, NMR, and UV-Vis.